Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study

被引:6
|
作者
Nascimento, Ananda Quaresma [1 ]
Dantas, Diego Bessa [1 ]
Melo, Giovana Salomao [1 ]
Gomes, Fabiana de Campos [2 ]
de Melo Neto, Joao Simao [1 ]
机构
[1] Fed Univ Para UFPA, Inst Hlth Sci, Belem, Para, Brazil
[2] Med Sch Faceres FACERES, Sao Jose Do Rio Preto, SP, Brazil
来源
PLOS ONE | 2022年 / 17卷 / 09期
关键词
INFLAMMATORY-BOWEL-DISEASE; RISK; SURVIVAL; HEALTH; STATE; METAANALYSIS; PREVENTION; TRENDS; COLON;
D O I
10.1371/journal.pone.0274572
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer (CRC) caused 261,060 deaths in Brazil over a 20-year period, with a tendency to increase over time. This study aimed to verify the sociodemographic factors predicting higher mortality caused by CRC and survival rates. Moreover, we aimed to verify whether the performance of screening, diagnostic and treatment procedures had an impact on mortality. Ecological observational study of mortality due to CRC was conducted in Brazil from 2000-2019. The adjustment variable was age, which was used to calculate the age-standardized mortality rate (ASMR). The exposure variables were number of deaths and ASMR. Outcome variables were age-period-cohort, race classification, marital status, geographic region, and screening, diagnostic, and treatment procedures. Age-period-cohort analysis was performed. ANOVA and Kruskal-Wallis test with post hoc tests were used to assess differences in race classification, marital status, and geographic region. Multinomial logistic regression was used to test for interaction among sociodemographic factors. Survival analysis included Kaplan-Meier plot and Cox regression analysis were performed. Multivariate linear regression was used to test prediction using screening, diagnosis, and treatment procedures. In Brazil, mortality from CRC increased after age 45 years. The highest adjusted mortality rates were found among white individuals and in the South of the country (p < 0.05). Single, married, and widowed northern and northeastern persons had a higher risk of death than legally separated southern persons (p < 0.05). Lower survival rates were observed in brown and legally separated individuals and residents from the North (p < 0.05). An increase in first-line chemotherapy and a decrease in second-line chemotherapy were associated with high mortality in the north (p<0.05). In the south, second-line chemotherapy and abdominoperineal rectal resection were associated with high mortality (p < 0.05). Regional differences in sociodemographic factors and clinical procedures can serve as guidelines for adjusting public health policies.
引用
收藏
页数:18
相关论文
共 44 条
  • [41] PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
    Pizzuti, Laura
    Krasniqi, Eriseld
    Sperduti, Isabella
    Barba, Maddalena
    Gamucci, Teresa
    Mauri, Maria
    Veltri, Enzo Maria
    Meattini, Icro
    Berardi, Rossana
    Di Lisa, Francesca Sofia
    Natoli, Clara
    Pistelli, Mirco
    Iezzi, Laura
    Risi, Emanuela
    D'Ostilio, Nicola
    Tomao, Silverio
    Ficorella, Corrado
    Cannita, Katia
    Riccardi, Ferdinando
    Cassano, Alessandra
    Bria, Emilio
    Fabbri, Maria Agnese
    Mazzotta, Marco
    Barchiesi, Giacomo
    Botticelli, Andrea
    D'Auria, Giuliana
    Ceribelli, Anna
    Michelotti, Andrea
    Russo, Antonio
    Salimbeni, Beatrice Taurelli
    Sarobba, Giuseppina
    Giotta, Francesco
    Paris, Ida
    Saltarelli, Rosa
    Marinelli, Daniele
    Corsi, Domenico
    Capomolla, Elisabetta Maria
    Sini, Valentina
    Moscetti, Luca
    Mentuccia, Lucia
    Tonini, Giuseppe
    Raffaele, Mimma
    Marchetti, Luca
    Minelli, Mauro
    Ruggeri, Enzo Maria
    Scavina, Paola
    Bacciu, Olivia
    Salesi, Nello
    Livi, Lorenzo
    Tinari, Nicola
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [42] Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
    Burn, John
    Sheth, Harsh
    Elliott, Faye
    Reed, Lynn
    Macrae, Finlay
    Mecklin, Jukka-Pekka
    Moeslein, Gabriela
    McRonald, Fiona E.
    Bertario, Lucio
    Evans, D. Gareth
    Gerdes, Anne-Marie
    Ho, Judy W. C.
    Lindblom, Annika
    Morrison, Patrick J.
    Rashbass, Jem
    Ramesar, Raj
    Seppala, Toni
    Thomas, Huw J. W.
    Pylvanainen, Kirsi
    Borthwick, Gillian M.
    Mathers, John C.
    Bishop, D. Timothy
    LANCET, 2020, 395 (10240) : 1855 - 1863
  • [43] Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group
    Giessen, C.
    Graeven, U.
    Laubender, R. P.
    Modest, D. P.
    Schulz, C.
    Porschen, R.
    Schmiegel, W.
    Reinacher-Schick, A.
    Hegewisch-Becker, S.
    Stintzing, S.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 3051 - 3055
  • [44] The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study
    Steventon, Luke
    Kipps, Emma
    Man, Kenneth K. C.
    Roylance, Rebecca
    Forster, Martin D.
    Wong, Ian C. K.
    Baser, Michael
    Miller, Rowan E.
    Nicum, Shibani
    Shah, Samixa
    Almossawi, Ofran
    Chambers, Pinkie
    EUROPEAN JOURNAL OF CANCER, 2024, 210